Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2009 2
2011 2
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
The colorectal microRNAome.
Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE. Cummins JM, et al. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92. doi: 10.1073/pnas.0511155103. Epub 2006 Feb 27. Proc Natl Acad Sci U S A. 2006. PMID: 16505370 Free PMC article.
MicroRNA profiling differentiates colorectal cancer according to KRAS status.
Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P, Knuutila S. Mosakhani N, et al. Genes Chromosomes Cancer. 2012 Jan;51(1):1-9. doi: 10.1002/gcc.20925. Epub 2011 Sep 15. Genes Chromosomes Cancer. 2012. PMID: 21922590
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Michael MZ, et al. Mol Cancer Res. 2003 Oct;1(12):882-91. Mol Cancer Res. 2003. PMID: 14573789 Free article.
MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease.
Chang KH, Miller N, Kheirelseid EA, Lemetre C, Ball GR, Smith MJ, Regan M, McAnena OJ, Kerin MJ. Chang KH, et al. Int J Colorectal Dis. 2011 Nov;26(11):1415-22. doi: 10.1007/s00384-011-1279-4. Epub 2011 Jul 8. Int J Colorectal Dis. 2011. PMID: 21739196
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M. Arndt GM, et al. BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374. BMC Cancer. 2009. PMID: 19843336 Free PMC article.
MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.
Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR. Mishra PJ, et al. PLoS One. 2009 Dec 24;4(12):e8445. doi: 10.1371/journal.pone.0008445. PLoS One. 2009. PMID: 20041160 Free PMC article.